iBio, Inc. Appoints Dr. Pamela Bassett to Board of Directors

NEWARK, Del.--(BUSINESS WIRE)--iBio, Inc. (OTCBB: IBPM) announced today the appointment of Dr. Pamela Bassett to its Board of Directors. Dr. Bassett is Managing Director of Life Sciences Research at Cantor Fitzgerald & Company, a leading global financial services provider to the institutional equity and fixed-income markets.

Back to news